Sonic Healthcare Limited
SHL
Rang in Aktien
#2864
Sonic Healthcare Limited delivers medical diagnostic services to a diverse... Sonic Healthcare Limited delivers medical diagnostic services to a diverse clientele, including medical professionals, hospitals, public health organizations, and individual patients. The company's services encompass a broad spectrum of laboratory medicine and pathology testing, covering biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal diagnostics, toxicology, and other related functions. Furthermore, Sonic provides extensive radiology services, such as magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. Its offerings also extend to primary care medical services, featuring general practice clinics, occupational health, specialized skin cancer clinics, after-hours GP services, IT solutions for general practices, and various community-based healthcare programs. Operating internationally, the company has a significant presence in Australia, the United Kingdom, Ireland, the United States, Germany, Switzerland, New Zealand, and Belgium. Founded in 1934, Sonic Healthcare Limited is headquartered in Sydney, Australia.
Aktienkurs
$13.35
Marktkapitalisierung
$6.60B
Veränderung (1 Tag)
1.83%
Veränderung (1 Jahr)
-5.13%
Land
AU
Handel Sonic Healthcare Limited (SHL)
Kategorie
Healthcare
Gewinn für Sonic Healthcare Limited (SHL)
Gewinn im Jun 2026 TTM: $581.53M
Laut den aktuellen Finanzberichten von Sonic Healthcare Limited betragen die aktuellen Gewinne des Unternehmens $581.53M. Im Jahr 2024 erzielte das Unternehmen einen Gewinn von $487.85M, ein Rückgang im Vergleich zu dem Gewinn im Jahr 2023, der $620.44M betrug. Die auf dieser Seite angezeigten Gewinne sind die Gewinne vor Zinsen und Steuern, auch bekannt als EBIT.
Gewinnverlauf von Sonic Healthcare Limited von 2000 bis 2026
Gewinn am Ende jedes Jahres
| Jahr | Gewinn | ändert |
|---|---|---|
| 2026 (TTM) | $581.53M | 17.65% |
| 2025 | $494.30M | 1.32% |
| 2024 | $487.85M | -21.37% |
| 2023 | $620.44M | -56.70% |
| 2022 | $1.43B | 4.50% |
| 2021 | $1.37B | 184.25% |
| 2020 | $482.35M | -4.91% |
| 2019 | $507.24M | 11.00% |
| 2018 | $456.95M | 3.07% |
| 2017 | $443.36M | -0.42% |
| 2016 | $445.22M | 24.81% |
| 2015 | $356.72M | -26.56% |
| 2014 | $485.74M | 19.92% |
| 2013 | $405.04M | -5.17% |
| 2012 | $427.14M | 2.04% |
| 2011 | $418.61M | 27.85% |
| 2010 | $327.42M | 62.12% |
| 2009 | $201.96M | -36.56% |
| 2008 | $318.35M | 29.08% |
| 2007 | $246.63M | 25.90% |
| 2006 | $195.89M | 69.95% |
| 2005 | $115.26M | 60.97% |
| 2004 | $71.61M | 36.20% |
| 2003 | $52.57M | 41.85% |
| 2002 | $37.06M | 31.08% |
| 2001 | $28.27M | 16.52% |
| 2000 | $24.26M | 0.00% |
Gewinn ähnlicher Unternehmen oder Konkurrenten
| Unternehmen | Gewinn | Gewinnunterschied | Land |
|---|---|---|---|
| $7.61B | 1,208.44% |
US
|
|
| $4.76B | 718.87% |
US
|
|
| $-252.70M | -143.45% |
US
|
|
| - | - |
CN
|
|
| $1.66B | 185.11% |
US
|
